LYTIR

Company · CVS

CVS Health Corporation

Name as listed on its exchange; filed with the SEC as CVS HEALTH Corp.

Nasdaq's symbol directory lists CVS on the New York Stock Exchange as “CVS Health Corporation Common Stock”.

In the 12 months to Nov 19, 2026: insiders bought on 1 occasion ($2.0M); insiders sold on 4 occasions ($323.7M); 1 filing by holders of 5% or more; 12 congressional trade disclosures; 4 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC · Appeared in No. 51, No. 47, No. 44

Insider purchases and sales, by month (last 12 months)Insider purchases: $2.0M in total; Insider sales: $323.7M in total.May: Insider sales $323.7MNov: Insider purchases $2.0MDecJanFebMarAprMayJunJulAugSepOctNov$2.0M$323.7M
Insider purchases above the line: $2.0MInsider sales below: $323.7M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Larry Robbins sold on 3 days latest May 21, 2026 sold $317.5M
  2. Tilak Mandadi, EVP, Chief Exp & Tech Officer sold on 1 day latest May 8, 2026 sold $6.2M
  3. Prem S. Shah, EVP and Group President bought on 1 day latest Nov 6, 2026 bought $2.0M
Every trade (5)
  1. BUYPrem S. Shah, EVP and Group President bought Nov 6, 2026 23,855 shares filing $2.0M
  2. SELLLarry Robbins sold May 21, 2026 370,462 shares filing $34.6M
  3. SELLLarry Robbins sold May 20, 2026 1,018,000 shares 4 legs combined filing $95.5M
  4. SELLLarry Robbins sold May 19, 2026 1,983,538 shares 2 legs combined filing $187.3M
  5. SELLTilak Mandadi, EVP, Chief Exp & Tech Officer sold May 8, 2026 69,551 shares filing $6.2M

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Dodge & Cox filed Aug 13, 2026 Schedule 13G/A passive 50,012,765 shares filing 3.9%

Congress · STOCK Act

The Althing

Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.

  1. Rohit Khanna (D-CA17): Sale Sep 4, 2026 reported Oct 7, 2026 one of 325 trades the member reported that day House owner: spouse $15,001 - $50,000
  2. Rohit Khanna (D-CA17): Sale Aug 24, 2026 reported Sep 4, 2026 one of 178 trades the member reported that day House owner: spouse $1,001 - $15,000
  3. Rohit Khanna (D-CA17): Purchase Jun 2, 2026 reported Jul 6, 2026 one of 375 trades the member reported that day House owner: dependent $1,001 - $15,000
  4. Rohit Khanna (D-CA17): Purchase May 15, 2026 reported Jun 9, 2026 one of 504 trades the member reported that day House owner: spouse $1,001 - $15,000
  5. Rohit Khanna (D-CA17): Purchase May 1, 2026 reported Jun 9, 2026 one of 504 trades the member reported that day House owner: dependent $1,001 - $15,000
  6. Rohit Khanna (D-CA17): Purchase Apr 13, 2026 reported May 11, 2026 one of 348 trades the member reported that day House owner: spouse $1,001 - $15,000
  7. Alan Armstrong (R-OK): Purchase Mar 27, 2026 reported Jul 21, 2026 one of 703 trades the member reported that day Senate Stock $1,001 - $15,000
  8. Michael T. McCaul (R-TX10): Purchase Feb 20, 2026 reported Mar 10, 2026 one of 112 trades the member reported that day House owner: spouse $15,001 - $50,000
  9. John Boozman (R-AR): Purchase Jan 29, 2026 reported Feb 15, 2026 one of 36 trades the member reported that day Senate Stock $1,001 - $15,000
  10. Rohit Khanna (D-CA17): Sale Jan 29, 2026 reported Feb 6, 2026 one of 878 trades the member reported that day House owner: spouse $1,001 - $15,000
  11. Michael T. McCaul (R-TX10): Sale Jan 13, 2026 reported Feb 11, 2026 one of 49 trades the member reported that day House owner: spouse $15,001 - $50,000
  12. Dwight Evans (D-PA03): Sale Nov 21, 2025 reported May 15, 2026 one of 5 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000

Executive branch · OGE Form 278-T

Reported by the President

6 confirmed trades on scanned reports whose security name matches this company's own filed name exactly (letter case, punctuation and Inc/Corp-style endings aside). All of Donald J. Trump's reports

  1. Sale: CVS HEALTH CORP Jul 31, 2026 reported Sep 8, 2026 President Donald J. Trump Periodic Transaction Report 09.08.26 $100,001 – $250,000
  2. Purchase: CVS HEALTH CORP May 15, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (2) $1,001 – $15,000
  3. Purchase: CVS HEALTH CORPORATION May 11, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (2) $1,001 – $15,000
  4. Purchase: CVS HEALTH CORP Apr 27, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (1) $50,001 – $100,000
  5. Purchase: CVS HEALTH CORPORATION Apr 27, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (1) $100,001 – $250,000
  6. Purchase: CVS HEALTH CORP Apr 15, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (1) $15,001 – $50,000

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Regulation FD disclosure filing Nov 4, 2026
  2. Results of operations and financial condition filing Nov 4, 2026
  3. Departure or appointment of directors or officers; Regulation FD disclosure filing Aug 17, 2026
  4. Results of operations and financial condition filing Aug 5, 2026

Federal contracts · USAspending.gov

Federal contracts

1 contract award first obligated in the last 12 months to the company or a subsidiary it lists in its 10-K, $7.0M in total obligated as USAspending.gov lists each award when Lytir last read it. Largest first.

  1. Department of Health and Human Services Sep 25, 2026 to CVS HEALTHSPIRE PAYOR & LIFE SCIENCES LLC award $7.0M

Sources: SEC EDGAR (Forms 4, 144 and 8-K), USAspending.gov, OGE Form 278-T reports on whitehouse.gov and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.